文献速递治疗药物监测与药物基因组学肝肾功能剂量调整

成人肾移植受者联用他克莫司时霉酚酸酯群体药动学模型的外部系统评价

Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.
PubMed 文献 · Br J Clin Pharmacol · 2019-02-05

该研究用独立数据集系统评价了已发表的成人肾移植受者联用他克莫司时霉酚酸酯(MMF)群体药动学(popPK)模型的外部预测性能。共纳入45例患者的50条完整药动学曲线,评价11个模型;多数模型预测误差在±30%以内的比例不足50%,贝叶斯 forecasting 可改善预测性,含肝肠循环(EHC)的二房室模型并不优于常规二房室模型。结论提示已发表模型预测性能不理想,MMF临床应用需进行治疗药物监测。

要点

  • 已发表MMF popPK模型外部预测性能不佳,多数模型预测误差±30%以内比例不足50%。
  • 贝叶斯 forecasting 可改善模型预测性,但整体模型变异大。
  • 含肝肠循环的二房室模型预测性能不优于常规二房室模型。

核心结论

  • 已发表MMF popPK模型变异大且预测性能不理想,提示MMF临床应用需进行治疗药物监测。

研究设计与样本

  • 采用独立数据集对已发表的成人肾移植受者联用他克莫司时MMF popPK模型进行外部预测性能评价。
  • 评价数据集包含45例患者的50条完整药动学曲线,共识别并评价11个已发表popPK模型。

主要发现

  • 基于预测的诊断中,多数已发表模型的预测误差在±30%以内的比例不足50%。
  • 预测校正和变异校正视觉预测检查及后验预测检查显示多数模型观测值与模拟值差异较大。
  • 所有模型的标准化预测分布误差不服从正态分布。
  • 贝叶斯 forecasting 显示模型预测性有所改善。
  • 含肝肠循环过程的二房室模型预测性能不优于常规二房室模型。

临床怎么用

  • 临床使用MMF时应进行治疗药物监测以应对已发表模型预测性能不理想的问题。

局限性

  • 评价数据集仅包含45例患者的50条完整药动学曲线,样本量有限。
  • 已发表模型预测性能受结构模型等因素影响,需进一步研究纳入潜在协变量以探讨关键影响因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Various mycophenolate mofetil (MMF) population pharmacokinetic (popPK) models have been developed to describe its PK characteristics and facilitate its optimal dosing in adult kidney transplant recipients co-administered with tacrolimus. However, the external predictive performance has been unclear. Thus, this study aimed to comprehensively evaluate the external predictability of published MMF popPK models in such populations and investigate the potential influencing factors. METHODS: The external predictability of qualified popPK models was evaluated using an independent dataset. The evaluation included prediction- and simulation-based diagnostics, and Bayesian forecasting. In addition, factors influencing model predictability, especially the impact of structural models, were investigated. RESULTS: Fifty full PK profiles from 45 patients were included in the evaluation dataset and 11 published popPK models were identified and evaluated. In prediction-based diagnostics, the prediction error within ±30% was less than 50% in most published models. The prediction- and variability-corrected visual predictive check and posterior predictive check showed large discrepancies between the observations and simulations in most models. Moreover, the normalized prediction distribution errors of all models did not follow a normal distribution. Bayesian forecasting demonstrated an improvement in the model predictability. Furthermore, the predictive performance of two-compartment (2CMT) models incorporating the enterohepatic circulation (EHC) process was not superior to that of conventional 2CMT models. CONCLUSIONS: The published models showed large variability and unsatisfactory predictive performance, which indicated that therapeutic drug monitoring was necessary for MMF clinical application. Further studies incorporating potential covariates need to be conducted to investigate the key factors influencing model predictability of MMF.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang HX, Sheng CC, Liu LS, et al. Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus. Br J Clin Pharmacol. 2019. PMID: 30597603. doi:10.1111/bcp.13850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。